New drug YL201 takes on tough esophageal cancer
NCT ID NCT07487896
First seen Jun 25, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This large Phase 3 trial tests a new drug called YL201 against standard chemotherapy in 440 people with advanced esophageal cancer that has worsened after initial treatment. YL201 is a targeted therapy designed to deliver chemo directly to cancer cells. The study aims to see if it helps people live longer and with fewer side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- YL201 (a targeted drug that delivers chemotherapy to cancer cells)
- What this could lead to
- If it works, this could offer a new treatment option for people with advanced esophageal cancer when standard therapy stops working.
- What could go wrong
- This is an early-stage Phase 3 trial, so results are not yet known. The drug may not work better than current chemo and could have side effects like infusion reactions or organ damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
101
RECRUITINGJinan, Shandong, 250117, China
-
102
RECRUITINGAnyang, Henan, China
-
103
RECRUITINGZhengzhou, Henan, China
-
104
RECRUITINGZhengzhou, Henan, China
-
105
RECRUITINGLuoyang, Henan, China
-
106
RECRUITINGShanghai, Shanghai Municipality, China
-
107
RECRUITINGNanjing, Jiangsu, China
-
108
RECRUITINGHangzhou, Zhejiang, China
-
109
RECRUITINGHangzhou, Zhejiang, China
-
110
NOT_YET_RECRUITINGFuzhou, Fujian, China
-
111
RECRUITINGChengdu, Sichuan, China
-
112
RECRUITINGNanning, Guangxi, China
-
113
RECRUITINGWuhan, Hubei, China
-
114
RECRUITINGWuhan, Hubei, China
-
115
RECRUITINGKunming, Yunnan, China
-
116
RECRUITINGChengdu, Sichuan, China
-
117
RECRUITINGNanchang, Jiangxi, China
-
118
RECRUITINGChengdu, Sichuan, China
-
119
RECRUITINGChongqing, Chongqing Municipality, China
-
120
RECRUITINGChongqing, Chongqing Municipality, China
-
121
RECRUITINGNanchang, Jiangxi, China
-
122
RECRUITINGHarbin, Heilongjiang, China
-
123
RECRUITINGTaiyuan, Shanxi, China
-
124
RECRUITINGTianjin, Tianjin Municipality, China
-
125
RECRUITINGChangchun, Jilin, China
-
126
RECRUITINGShenyang, Niaoning, China
-
127
RECRUITINGXi’an, Shanxi, China
-
128
RECRUITINGJilin City, Jilin, China
-
129
RECRUITINGBeijing, Beijing Municipality, China
-
130
RECRUITINGÜrümqi, Xinjiang, China
-
132
RECRUITINGNanyang, Henan, China
-
133
RECRUITINGHefei, Anhui, China
-
134
RECRUITINGShanghai, Shanghai Municipality, China
-
135
RECRUITINGBengbu, Anhui, China
-
136
RECRUITINGXuzhou, Jiangsu, China
-
137
RECRUITINGQingdao, Shandong, China
-
138
RECRUITINGLinyi, Shandong, China
-
139
RECRUITINGJinan, Shandong, China
-
140
RECRUITINGSuzhou, Jiangsu, China
-
141
RECRUITINGLinyi, Shandong, China
-
142
RECRUITINGZhengzhou, Henan, China
-
143
RECRUITINGHefei, Anhui, China
-
144
RECRUITINGAnqing, Anhui, China
-
145
RECRUITINGXiamen, Fujian, China
-
146
RECRUITINGSuining, Sichuan, China
-
147
RECRUITINGFuzhou, Fujian, China
-
148
RECRUITINGWuhan, Hubei, China
-
149
RECRUITINGGuangzhou, Guangdong, China
-
150
RECRUITINGNanning, Guangxi, China
-
151
RECRUITINGChangsha, Hunan, China
-
152
RECRUITINGNanchong, Sichuan, China
-
153
RECRUITINGMianyang, Sichuan, China
-
154
RECRUITINGGuangzhou, Guangdong, China
-
155
RECRUITINGYichang, Hubei, China
-
156
RECRUITINGShijiazhuang, Hebei, China
-
157
RECRUITINGShenyang, Niaoning, China
-
158
RECRUITINGHandan, Hebei, China
-
159
RECRUITINGShijiazhuang, Hebei, China
-
160
RECRUITINGShenyang, Niaoning, China
-
161
RECRUITINGBeijing, Beijing Municipality, China
-
162
RECRUITINGXi’an, Shanxi, China
-
163
RECRUITINGYinchuan, Ningxia, China
-
165
RECRUITINGHuai'an, Jiangsu, China
-
166
RECRUITINGTengzhou, Shandong, China
-
167
RECRUITINGTai’an, Shandong, China
-
168
RECRUITINGMeizhou, Guangzhou, China
-
169
RECRUITINGShantou, Guangzhou, China
-
170
RECRUITINGHarbin, Heilongjiang, China
-
171
RECRUITINGTaizhou, Jiangsu, China
-
172
RECRUITINGShanghai, Shanghai Municipality, China
-
173
RECRUITINGShanghai, Shanghai Municipality, China
-
174
RECRUITINGHangzhou, Zhejiang, China
-
175
RECRUITINGLanzhou, Gansu, China
-
176
RECRUITINGHandan, Hebei, China
-
177
RECRUITINGNantong, Jiangsu, China
-
178
RECRUITINGJinan, Shandong, China
-
179
RECRUITINGWenzhou, Zhejiang, China
-
180
RECRUITINGLangfang, Hebei, China
-
182
RECRUITINGChangsha, Hunan, China
-
183
RECRUITINGBeijing, Beijing Municipality, China
-
184
RECRUITINGFoshan, Guangzhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug boost the fight against esophageal cancer?
- Can a flexible dosing schedule improve esophageal cancer treatment?
- New drug cocktail targets Hard-to-Treat cancers
- Smart MRI tailors cancer therapy for better outcomes
- New drug cocktail aims to fight tough esophageal cancer
- New hope for tough esophageal cancer: drug combo targets gene mutations